The New York Times reported today on a study that found most women with ovarian cancer receive inadequate care. The article discusses research presented at the 2013 meeting of the Society of Gynecologic Oncologists (SGO), which found that women are more likely to get optimal care when treated at a medical center that handles a … Continued
Calaneet Balas, OCNA’s Chief Executive Officer, testified before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Wednesday, March 13. Her remarks touched on the importance of federal funding for ovarian cancer education and research through the National Cancer Institute and Centers for Disease Control and Prevention. Summing up our … Continued
Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not the treatment received in the clinical trial. Patients interested in clinical trials may also be more involved in decision making, which some believe affects outcomes. … Continued
For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for patients enrolled in private insurance plans. Preventive services are provided without cost sharing to people enrolled in private plans that were established after August 1, … Continued
Michele Robinson came up with the idea for her cancer support group, “You’ll Never Walk Alone,” during her first chemotherapy treatment for ovarian cancer in November 2004. “I was looking around the room and that song popped into my head. It was true—even though you do experience cancer yourself, no one knows what you feel … Continued
New research published in Human Reproduction Update provides additional evidence that in vitro fertilization (IVF) does not increase women’s risk for ovarian, endometrial, and cervical cancer. Researchers have wondered if fertility treatments like IVF, which require the use of ovulation-stimulating drugs and the puncturing of the ovaries to retrieve eggs, increased women’s risk of gynecologic cancers. Some … Continued
In a report issued this month, the American Cancer Society released new statistics on cancer in African Americans. Overall, cancer death rates among both African American men and women have declined, yet African Americans still have the highest death rate and shortest survival of any ethnic group for cancer. However, for ovarian cancer, both incidence … Continued
A study of the medical records of more than 67,000 women who underwent fertility treatment found that fertility treatments did not effect the risk of breast or uterine cancer, and may slightly increase the risk of ovarian cancer. Researchers are not sure if the risk of ovarian cancer was due to chance or the drugs/IVF … Continued
A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by histological subtype, menopausal status, and post-menopausal hormone (HRT) use. Results showed that while obesity does appear to increase risk of less common types of ovarian … Continued
The University of Texas MD Anderson Cancer Center is one of the nation’s preeminent hospitals for cancer care. Located in Houston, Texas, MD Anderson’s Blanton-Davis Ovarian Cancer Research Program was created in 1996 as a critical step toward the goal of eradicating ovarian cancer. The program was the nation’s first formal, comprehensive ovarian cancer research … Continued
A new report from the American Cancer Society estimates cancer incidence and mortality rates for African Americans. In the case of ovarian cancer, both incidence and mortality are lower for African American women than for white women. Ovarian cancer incidence for African American women is 74 percent of the rate for white women; death rates … Continued
A new study of mice with prostate cancer indicated that stress can hinder the effectiveness of anti-cancer therapies. In this mouse model, the use of beta-blockers did prevent stress from accelerating cancer growth. The pathway will now be tested in human prostate cells. Read an article about the study here and the journal article here. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
